Based on these data, we suggest that BCAR3 controls the balance between Rac1 and RhoA signaling in invasive breast cancer cells and, through this activity, functions as a positive regulator of actin cytoskeletal/adhesion remodeling and cell motility. Here, RAC1 is linked to breast carcinoma.